Sangamo BioSciences Announces Efficient Generation of Transgenic Pigs Using Zinc Finger Nuclease Technology

Sangamo BioSciences, Inc. SGMO announced the publication of a study demonstrating the use of zinc finger nucleases to produce genetically modified pigs. The study, which was published in the Proceedings of the National Academy of Sciences, represents a significant advancement in the development of improved, less immunogenic animal tissue as a source for transplant into humans. Transplantation is considered to be the best treatment option for thousands of patients every year whose own organs are damaged or diseased. However, the supply of human organ and tissues available for transplantation is insufficient to satisfy the demand.